Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer

Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer (link is external)
Mesh Headings: 
Prostate-Specific Antigen |
Prostatic Neoplasms |
Male |
Risk Assessment |
Guidelines Portal reference number: 
2518
Publication Date: 
2016
Guideline Status: 
First edition
Setting of care: 
Primary/Community care
Secondary care
Tertiary care
Population Life Stage: 
Adult (19-64 years)
Adult, Aged (65+ years)
Intended Users: 
Allied health professionals not otherwise stated
General practitioners
Medical specialists
Nurses
Population Subgroups considered: 
Aboriginal and Torres Strait Islander people
Number of recommendations: 
45
Organisations involved in producing the guideline: 
Organisation: 
Prostate Cancer Foundation of Australia
Involvement in guidelineFurther information icon
Primary Developer
Organisation: 
Cancer Council Australia
Involvement in guidelineFurther information icon
Primary Developer
Systematic Literature Review?Further information icon
Yes
Interest declarationFurther information icon
Yes
Funding statementFurther information icon
Yes
NHMRC ApprovedFurther information icon
Yes
NHMRC Approval valid until: 
Monday, 2 November 2020
Date of Inclusion: 
22 Jan 2016